Sum Lam
Impact in
-
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Blood Pressure and Hypertension Studies 4
- Atrial Fibrillation Management and Outcomes 3
-
- Diabetes Treatment and Management 5
- Diabetes Management and Research 3
- Co-authors
- Irving H. Gomolin (1 shared paper)Priti N. Patel (1 shared paper)Tomasz Z. Jodlowski (2 shared papers)Olga Hilas (1 shared paper)Sharon See (1 shared paper)Christine M. Ruby (1 shared paper)Tran H. Tran (1 shared paper)Kathryn Choon Beng Tan (1 shared paper)
- Journals
- Cardiology in Review (12 papers)Early China (1 paper)Journal of Diabetes (1 paper)Annals of Pharmacotherapy (1 paper)American Journal of Health-System Pharmacy (1 paper)
- Partner nations
- United StatesTaiwanHong Kong
In The Last Decade
Sum Lam
29 papers receiving 363 citations
Peers
Comparison fields: 5 of 109
- Pharmacology 81
- Geriatrics and Gerontology 15
- Endocrinology, Diabetes and Metabolism 62
- Applied Microbiology and Biotechnology 7
- Psychiatry and Mental health 47
Countries citing papers authored by Sum Lam
This map shows the geographic impact of Sum Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sum Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sum Lam more than expected).
Fields of papers citing papers by Sum Lam
This network shows the impact of papers produced by Sum Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sum Lam. The network helps show where Sum Lam may publish in the future.
Co-authors
The 23 scholars most cited alongside Sum Lam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 78 | |
| 2 | 2007 | 44 | |
| 3 | 2007 | 27 | |
| 4 | 2008 | 24 | |
| 5 | 2017 | 22 | |
| 6 | Pharmacologic management of overactive bladder. | 2007 | 21 |
| 7 | 2006 | 20 | |
| 8 | 2011 | 19 | |
| 9 | 2007 | 14 | |
| 10 | 2005 | 14 | |
| 11 | 2009 | 13 | |
| 12 | 2022 | 9 | |
| 13 | 2020 | 9 | |
| 14 | 2017 | 8 | |
| 15 | 2009 | 7 | |
| 16 | 2015 | 7 | |
| 17 | 2019 | 6 | |
| 18 | 2010 | 6 | |
| 19 | 2003 | 6 | |
| 20 | 2018 | 5 |
About Sum Lam
Sum Lam is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology and Internal Medicine, having authored 29 papers that have together received 387 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Blood Pressure and Hypertension Studies (4 papers), Diabetes Management and Research (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Pharmacology and Obesity Treatment (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Pharmacology (81 citations), Geriatrics and Gerontology (15 citations), Endocrinology, Diabetes and Metabolism (62 citations), Applied Microbiology and Biotechnology (7 citations) and Psychiatry and Mental health (47 citations). Sum Lam has collaborated with scholars based in United States, Taiwan and Hong Kong. Frequent co-authors include Irving H. Gomolin, Priti N. Patel, Tomasz Z. Jodlowski, Olga Hilas, Sharon See, Christine M. Ruby, Tran H. Tran, Kathryn Choon Beng Tan, Melissa Fazzari and Katie Lee. Their work appears in journals such as Cardiology in Review, Early China, Journal of Diabetes, Annals of Pharmacotherapy and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.